Santosh Kottayil
Director/Board Member chez ACASTI PHARMA INC.
Fortune : 2 M $ au 31/03/2024
Profil
Santosh George Kottayil was the founder of InSys Therapeutics, Inc. which was founded in 2002, where he held the titles of President & Executive Vice President-Technology.
Dr. Kottayil is also the founder of Grace Therapeutics LLC.
Currently, he is a Director at Acasti Pharma, Inc. since 2023.
Previously, he worked as the Chief Operating Officer-US at Acasti Pharma, Inc. Dr. Kottayil earned a doctorate degree from the University of Kentucky.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/12/2023 | 494 698 ( 5,26% ) | 2 M $ | 31/03/2024 |
Postes actifs de Santosh Kottayil
| Sociétés | Poste | Début |
|---|---|---|
| ACASTI PHARMA INC. | Director/Board Member | 10/10/2023 |
Anciens postes connus de Santosh Kottayil
| Sociétés | Poste | Fin |
|---|---|---|
| ACASTI PHARMA INC. | Corporate Officer/Principal | 08/05/2023 |
Grace Therapeutics LLC
 Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Chief Executive Officer | 01/08/2021 |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Founder | - |
Formation de Santosh Kottayil
| University of Kentucky | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
